![Breast cancer treatment should be tailored to the tumour biology – not to its hormone-receptor status alone](/var/esmo/storage/images/esmo-daily-reporter/all-news/features/breast-cancer-treatment-should-be-tailored-to-the-tumour-biology-not-to-its-hormone-receptor-status-alone/8406408-4-eng-GB/breast-cancer-treatment-should-be-tailored-to-the-tumour-biology-not-to-its-hormone-receptor-status-alone_i770.jpg)
Breast cancer treatment should be tailored to the tumour biology – not to its hormone-receptor status alone
New insights into breast cancer immunology and genomics support further segmentation of patient subgroups and treatment approaches, says Prof. Sherene Loi